Multidrug resistance-associated protein 1 predicts relapse in iranian childhood acute lymphoblastic leukemia

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 5, 2012, Pages 2285-2289

  Mahjoubi, Frouzandeh ^a   Akbari, Soodeh ^a  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

Leukemia; MDR; Multidrug resistance associated protein (MRP1) gene; Real time RT PCR

Indexed keywords

ABCB1 PROTEIN, HUMAN; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; DRUG RESISTANCE; FEMALE; FOLLOW UP; GENETICS; HUMAN; MALE; MULTIDRUG RESISTANCE; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR RECURRENCE;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; P-GLYCOPROTEIN; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; REMISSION INDUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84872676521     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.5.2285     Document Type: Article

References (35)

1. Ambudkar SV, Dey S, Hrycyna CA, et al (1999). Biochemical, cellular and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol, 39, 361-98.
2. Borst P, Evers R, Kool M, Wijnholds JJ (2000). Title??? J Natl Cancer Inst, 92, 1295-302.
3. Bunting KD (2002). ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells, 20, 11-20.
4. Cole SPC, Bhardwaj G, Gerlach JH, et al (1992). Overexpression of a novel transporter gene in a multidrug resistant human lung cancer cell line. Science, 258, 1650.
5. Cole SP, Bhardwaj G, Gerlach JH, et al (1992). Science, 258, 1650-4.
6. Endicott JA, Ling V (1989).Title???. Annu Rev Biochem, 58, 137-71.
7. Fardel O Lecureur V, Guillouzo A (1996). The P-glycoprotein multidrug transporter. Gen Pharmacol, 27, 1283-91.
8. Gottesman MM, Fojo T, Bates SE (2002). Multidrug resistance in cancer, role of ATP-dependent transporters. Nat Rev Cancer, 2, 48-58.
9. Gottesman MM, Hrycyna CA, Schoenlein PV (1995). Genetic analysis of the multidrug transport. Annu Rev Genel, 29, 607-49.
10. Gottesman MM, Licht T, Zhou Y, et al (2000). Selectable markers for gene therapy. In Gene Therapy: Therapeutic Mechanisms and Strategies, ed. D Lasic, N Templeton, 16, 333-52.
11. Gottesman MM, Pastan I (1993). Title???. Annu Rev Biochem, 62, 385-427.
12. Gottesman MM, Fojo T, Bates SE (2002).Title???. Nat Rev Cancer, 2, 48-58.
13. Higgins CF (1992).Title???. Ann Rev Cell Biol, 8, 67-113.
14. Hipfner DR, Deeley RG, Cole SP (1999). Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta, 1461, 359-76.
15. Holleman A, Cheok MH, Den Boer ML, et al (2004). Gene expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med, 351, 533-42.
16. Jean-Pierre Marie, Olliver LeGrand (2003). Drug resistance in acute leukaemia and reversion. Turk J Med Sci, 33, 271-9.
17. Klein I, Sarkadi B, Varadi A (1999). Biochim Biophys Acta, 1461, 237-62.
18. Kool M, De Haas M, Scheffer GL, et al (1997). Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologs of the multidrug resistance-associated protein gene (MRP1), in human cancer cell line. Cancer Res, 57, 3537.
19. Kool M, Van Der Linden M, De Haas M, Baas F, Borst P (1999). Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res, 59, 175.
20. Krishna R, Mayer LD (2000). Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur J Pharm Sci, 11, 265-83.
21. Leslie EM, Deeley RG, Cole SP (2001). Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology, 167, 3-23.
22. Mitelman F (1991). ISCN Guidelines for Cancer Cytogenetics: Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger.
23. Plasschaert SL, Vellenga E, De Bont ES, et al (2003). High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children. Leuk Lymphoma, 44, 85-95.
24. Ros JE, Libbrecht L, Geuken M, Jansen PL, Roskams TA (2003). High expression of MDR1, MRP1and MRP3 in the hepatic progenitor cell compartment and hepatocytes in several human liver disease. J Pathol, 200, 553-60.
25. Sabine L, Plasschaert A, Eveline SJM (2005). Expression of multidrug resistance-associated proteins predicts prognosis in childhood and adult acute lymphoblastic leukemia. Clin Cancer Res, 11, 24.
26. Sauerbrey A, Voigt A, Writtig S, Hafer R, Zintl F (2002). Messenger RNA analysis of the multidrug resistance related protein (MRP1) and the lung resistance protein (LRP) in de novo and relapsed childhood acute lymphoblastic leukemia. Leuk Lymphoma, 43, 875-9.
27. Simon M, Schindler M (1994). Cell biological mechanisms of multidrug resistance in tumors. Proc Natl Acad Sci USA, 91, 3497.
28. Sonneveid P (2000). Multidrug resistance in haematological malignancies. J Intern Med, 247, 521-34.
29. Strautnieks SS, Bull LN, Knisely AS (1998). Nat Genet, 20, 233-8.
30. Taniguchi K, Wada M, Kohno K, et al (1996). A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Res, 56, 4124.
31. Thomas R (2000). Chemotherapy resistance in acute leukemia. Turk J Haematol, 17, 155-162.
32. Ueda K, Taguchi Y, Morishima M (1997).Title???. Semin Cancer Biol, 8, 151-9.
33. Wijnholds J, Mol CA, Van Deemter L, et al (2000). Multi-drug-resistance protein 5 is a multispecific organic an-ion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA, 97, 7476-81.
34. Wijnholds J, Mol CA, Van Deemter L, et al (2003). Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA, 97, 7476-81.
35. Yoshida M, Suzuki T, Komiva T, et al (2001). Induction of MRP5 and SMRP mRNA by Adriamycin exposure and its overexpression in human lung cancer cells resistant to Adriamycin. Int J Cancer, 94, 432-7.